Hui-Lin Pan Selected Research

AM-0902

1/2019

Endogenous transient receptor potential ankyrin 1 and vanilloid 1 activity potentiates glutamatergic input to spinal lamina I neurons in inflammatory pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Lin Pan Research Topics

Disease

44	Neuralgia (Stump Neuralgia) 12/2022 - 02/2002
40	Pain (Aches) 12/2022 - 09/2002
24	Hypersensitivity (Allergy) 01/2022 - 06/2003
22	Hypertension (High Blood Pressure) 01/2022 - 03/2006
22	Hyperalgesia 01/2021 - 02/2002
9	Chronic Pain 11/2019 - 02/2002
8	Diabetic Neuropathies (Diabetic Neuropathy) 11/2019 - 11/2003
5	Inflammation (Inflammations) 01/2022 - 06/2003
5	Peripheral Nervous System Diseases (PNS Diseases) 05/2019 - 01/2016
5	Neoplasms (Cancer) 01/2019 - 03/2014
4	Ischemia 03/2022 - 02/2002
3	Brain Injuries (Brain Injury) 03/2022 - 10/2018
3	Postherpetic Neuralgia 01/2021 - 04/2005
3	Peripheral Nerve Injuries 05/2019 - 09/2012
3	Painful Neuropathy 12/2017 - 08/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 07/2007 - 02/2002
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 10/2020 - 10/2018
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2020 - 10/2018
2	Infarction (Infarctions) 10/2018 - 07/2007
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2014 - 12/2009
2	Multiple Sclerosis 12/2014 - 12/2009
2	Myasthenia Gravis 12/2014 - 12/2009
2	Epilepsy (Aura) 09/2014 - 01/2010
1	Autoimmune Diseases (Autoimmune Disease) 12/2022
1	Visceral Pain 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Herpes Zoster 01/2021

Drug/Important Bio-Agent (IBA)

29	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 08/2009
23	Analgesics (Analgesic Drugs)IBA 01/2021 - 02/2002
10	Glutamic Acid (Glutamate)FDA Link 01/2022 - 02/2002
10	Opioid Analgesics (Opioids)IBA 01/2019 - 12/2002
9	Gabapentin (Neurontin)FDA LinkGeneric 01/2022 - 04/2005
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2010
8	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 01/2005
7	Peptides (Polypeptides)IBA 01/2022 - 10/2018
7	CannabinoidsIBA 01/2022 - 07/2009
7	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 06/2002
5	CalcineurinIBA 12/2022 - 01/2012
5	Calcineurin InhibitorsIBA 12/2022 - 04/2013
5	Streptozocin (Streptozotocin)FDA Link 11/2019 - 06/2002
5	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 04/2016
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 11/2014
5	Small Interfering RNA (siRNA)IBA 12/2018 - 02/2012
5	Casein Kinase II (Casein Kinase 2)IBA 10/2015 - 06/2011
4	Tacrolimus (Prograf)FDA LinkGeneric 12/2022 - 04/2013
4	AMPA Receptors (AMPA Receptor)IBA 01/2022 - 01/2012
4	Memantine (Namenda)FDA Link 01/2021 - 08/2009
4	Freund's AdjuvantIBA 02/2019 - 07/2009
4	Protein Kinase CIBA 01/2019 - 01/2016
4	CalpainIBA 10/2018 - 01/2012
4	N-Methylaspartate (NMDA)IBA 10/2017 - 08/2009
4	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2011 - 09/2002
3	AnionsIBA 03/2022 - 01/2018
3	CB2 Cannabinoid ReceptorIBA 01/2022 - 01/2016
3	resiniferatoxinIBA 01/2021 - 04/2003
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2017 - 09/2011
3	ChloridesIBA 01/2016 - 06/2012
3	gamma-Aminobutyric Acid (GABA)IBA 01/2016 - 02/2007
3	Cholinergic Agents (Cholinergics)IBA 11/2011 - 03/2003
3	BradykininIBA 07/2007 - 02/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2022 - 05/2014
2	CalciumIBA 01/2022 - 11/2019
2	Ion Channels (Ion Channel)IBA 01/2022 - 09/2014
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2022
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2021 - 01/2018
2	Calcium Channels (Calcium Channel)IBA 01/2021 - 05/2019
2	CytokinesIBA 02/2019 - 04/2013
2	Protein Kinases (Protein Kinase)IBA 02/2019 - 09/2017
2	Netrin-1IBA 01/2019 - 10/2016
2	iodoresiniferatoxinIBA 01/2019 - 09/2004
2	Angiotensin IIIBA 01/2019 - 11/2018
2	MuscarineIBA 12/2018 - 03/2003
2	InflammasomesIBA 01/2018 - 06/2015
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018 - 11/2013
2	GhrelinIBA 04/2017 - 01/2017
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2016 - 09/2012
2	4-Aminopyridine (4 Aminopyridine)FDA Link 12/2014 - 12/2009
2	Messenger RNA (mRNA)IBA 03/2014 - 12/2010
2	metabotropic glutamate receptor type 1IBA 03/2014 - 01/2010
2	Glycine Receptors (Glycine Receptor)IBA 02/2014 - 06/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2012 - 09/2010
2	GABA-B ReceptorsIBA 08/2008 - 03/2003
2	Capsaicin (Zostrix)FDA Link 04/2005 - 04/2003
2	AcidsIBA 01/2005 - 02/2002
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2003 - 09/2002
2	Neostigmine (Neostigmine Bromide)IBA 11/2003 - 03/2003
2	D-Penicillamine (2,5)- EnkephalinIBA 01/2003 - 12/2002
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2022
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Histone MethyltransferasesIBA 01/2020

Therapy/Procedure

18	Spinal Injections 01/2022 - 11/2003
6	Electroacupuncture 01/2022 - 07/2009
6	Drug Therapy (Chemotherapy) 05/2019 - 11/2014
4	Ligation 01/2018 - 02/2002
1	Organ Transplantation 12/2022